查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404810

植入式心臟整流去顫器市場規模、佔有率、趨勢分析報告：按 NYHA 類別、最終用途、產品類型、地區和細分市場預測，2024-2030 年

Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report By NYHA Class (NYHA Class I, NYHA Class II), By End-use (Hospitals, Ambulatory Surgical Centers), By Product Type, By Type, By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 174 Pages | 商品交期: 2-10個工作天內

價格

植入式心臟整流去顫器市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球植入式心臟整流去顫器市場預計將達到 58.6 億美元。

預計2024年至2030年該市場將以6.4%的複合年成長率成長。這一成長可歸因於多種因素，包括產品技術的進步、心臟麻痹發生率的增加、公眾對心臟健康意識的提高以及政府和醫療機構的支持政策。這些因素共同推動了心臟去顫器的需求，並有助於整體市場的擴張。

心血管和其他心臟疾病的盛行率不斷上升，推動了全球對心臟再同步治療設備 (CRT-D) 和植入式心臟整流去顫器(ICD) 的需求。心臟麻痹(SCA) 仍然是重要的死亡原因，其發生率和相關危險因子不斷增加。心臟衰竭對全球健康挑戰造成重大影響，增加了對 CRT-D 和心臟去顫器的需求。此外，心律異常的普遍存在，尤其是老年人和冠狀動脈疾病 (CAD) 患者，進一步推動了對 ICD 的需求。 CRT-D 和 ICD 在心血管疾病的治療和改善患者預後方面變得越來越重要。

ICD 市場受到了 COVID-19大流行的負面影響。選擇性手術的取消和對 COVID-19 患者的關注對 2020 年第一季的市場產生了影響。然而，大流行加速了遠端保健的採用，包括對心律不整患者的遠距監測。心律協會發布的指南強調限制面對面諮詢並提倡遠距醫療諮詢。 Biotronic 充分利用了這一趨勢，普及了配備家庭監控技術的植入式 CRM 設備。儘管心血管遠端監測有所成長，但在某些地區（包括一些歐盟國家）報銷仍然有限，阻礙了整體市場的擴張。調查對象國家尚未獲得用於心臟衰竭管理的遠端技術的報銷。

植入式心臟整流去顫器市場報告亮點

  • 根據產品類型，ICD 市場分為經靜脈植入式心臟整流去顫器(T-ICD) 和皮下植入式心臟整流去顫器(S-ICD)。 2023年，T-ICD細分市場將以89.83%的市場佔有率主導地位。
  • 依類型，ICD 市場分為單心室 ICD、雙心室 ICD 和雙心室 ICD。 2023年，雙心室設備細分市場佔據主導地位，銷售佔有率為44.33%。
  • 依NYHA等級，市場分為NYHA II級和NYHA III級。 NYHA II 類細分市場預計將在 2023 年以 67.72% 的佔有率主導市場，並在市場估計和預測期內以 6.6% 的複合年成長率成長最快。
  • 根據最終用途，ICD 市場分為醫院、門診手術中心等。預計到2023年，醫院細分市場將以86.67%的佔有率佔據市場主導地位，並在市場估計和預測期內以6.5%的最快複合年成長率成長。
  • 按地區分類，北美主導全球市場，2023年佔總市場佔有率的41.4%。北美擁有高度發展的醫療保健基礎設施，包括醫院、診所和醫療設施。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章植入式心臟整流去顫器市場變數與趨勢

  • 植入式心臟整流去顫器（ICD）市場前景
    • 母市場展望 -心率管理設備市場
    • 附隨市場前景
  • 市場動態
    • 市場促進因素影響分析
    • 市場抑制因素分析
  • 法律規範
    • 標準和合規性
    • 贖回場景
  • COVID-19感染疾病的影響
  • 心臟衰竭ICD 患者人數
  • 接受電池更換的 ICD 患者比例及併發症率
    • 接受電池更換的 ICD 患者百分比
    • 併發症率
  • ICD治療相關臨床實驗評價
    • 心肌病多部位刺激（Mustik）試驗
    • 多中心 Insync 隨機臨床評估（奇蹟）試驗
    • Hf（伴同性）試驗中藥物治療、起搏和去心房顫動的比較
    • 心臟再同步-HF (Care-HF) 試驗
    • 多中心自動心臟去顫器植入合併心臟再同步治療（Madit-crt）試驗
    • 丹麥研究評估植入式心臟整流去顫器對非缺血性心臟衰竭衰竭死亡率患者的療效（丹麥）試驗
    • 英國審判
  • 產業分析工具
    • 波特的分析
    • 宏觀經濟分析

第4章植入式心臟整流去顫器市場：產品類型分析

  • 2023 年和 2030 年產品類型變化分析和市場佔有率
  • 依產品類型
  • 植入式心臟整流去顫器(T-ICD)
    • 2018-2030年植入式心臟整流去顫器市場
  • 植入式心臟整流去顫器(S-ICD)
    • 皮下植入式心臟整流去顫器市場，2018-2030

第5章植入式心臟整流去顫器市場：類型分析

  • 2023年和2030年類型變化分析和市場佔有率
  • 按類型
  • 單腔ICD
    • 使用單腔 ICD 的患者的常見症狀
    • 單腔 ICD 市場，2018-2030 年
  • 雙腔室ICD
    • 使用雙腔 ICD 的患者的常見症狀
    • 雙腔室ICD 市場，2018-2030
  • 雙心室裝置
    • 雙心室裝置市場，2018-2030

第6章植入式心臟整流去顫器市場：NYHA 類別分析

  • 2023年和2030年尼哈級波動分析和市場佔有率
  • 按膝蓋等級
  • 尼哈II級
    • 尼哈 II 類市場，2018-2030
  • 尼哈Ⅲ級
    • Niha III 級市場，2018-2030

第7章植入式心臟整流去顫器市場：最終用途分析

  • 2023 年和 2030 年最終用途變化分析和市場佔有率
  • 按最終用途
  • 醫院
    • ICD植入的變化取決於醫院類型
    • 醫院市場，2018-2030
  • 門診手術中心
    • 門診手術中心市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第8章植入式心臟整流去顫器市場：區域估計和趨勢分析

  • 植入式心臟整流去顫器市場：區域展望
  • 北美洲
    • 2018-2030年北美植入式心臟整流去顫器市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲植入式心臟整流去顫器市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區植入式心臟整流去顫器市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲植入式心臟整流去顫器市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲植入式心臟整流去顫器市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭分析

  • 公司分類
  • Participants'Overview
  • 財務績效
  • 產品基準評效
  • 公司市場分析
    • 熱圖分析
  • Swot-analysis
    • Abbott
    • Medtronic
    • Biotronik Se &Co. Kg
    • Boston Scientific Corporation
    • Microport Scientific Corporation
    • Livanova Plc
  • 2023 年公司市場佔有率分析
  • 策略規劃
    • 併購
    • 產品發表會
    • 夥伴關係與協作
    • 產品核准
    • 其他
Product Code: GVR-4-68040-109-4

Implantable Cardioverter Defibrillator Market Growth & Trends:

The global implantable cardioverter defibrillator market size is projected to reach USD 5.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.4% from 2024 to 2030. The growth can be attributed to various factors, including advancements in product technology, the increasing prevalence of sudden cardiac arrest, growing public awareness about cardiac health, and supportive policies by governments and healthcare organizations. These factors collectively drive the demand for cardioverter defibrillators and contribute to the overall market expansion.

The global demand for cardiac resynchronization therapy devices (CRT-Ds) and implantable cardioverter defibrillators (ICDs) is fueled by the increasing prevalence of cardiovascular diseases and other heart ailments. Sudden cardiac arrest (SCA) remains a significant cause of mortality, with a rising incidence and associated risk factors. Heart failure contributes significantly to global health challenges and drives the need for CRT-Ds and defibrillators. In addition, the prevalence of abnormal heart rhythms, especially in older adults and individuals with coronary artery disease (CAD), further boosts the demand for ICDs. These factors highlight the growing importance of CRT-Ds and ICDs in addressing cardiovascular conditions and improving patient outcomes.

The ICD market was negatively impacted by the COVID-19 pandemic. The suspension of elective surgeries and the focus on COVID-19 patients affected the market during the first quarter of 2020. However, the pandemic accelerated the adoption of telehealth, including remote monitoring for patients with arrhythmias. Guidelines released by the Heart Rhythm Society emphasized limiting in-person visits and promoting remote care. Biotronik capitalized on this trend by promoting its implantable CRM devices with home monitoring technology. Despite the growth in cardiovascular remote monitoring, limited reimbursement in specific regions including some EU countries hindered the overall market expansion. Approximately 13 surveyed countries still do not provide reimbursement for remote technologies in the context of heart failure management.

Implantable Cardioverter Defibrillator Market Report Highlights:

  • Based on product type, the ICD market is classified into transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs). The T-ICDs segment dominated the market in 2023 with a revenue share of 89.83%.
  • Based on type, the ICD market is classified into single-chamber ICDs, dual-chamber ICDs, and biventricular devices segments. The biventricular devices segment dominated the market in 2023 with a revenue share of 44.33%.
  • Based on NYHA Class, the market is classified into NYHA Class II and NYHA Class III. The NYHA Class II segment dominated the market with a 67.72% share in 2023 and is estimated to grow at the fastest CAGR of 6.6% during the forecast period.
  • Based on end-use, the ICD market is classified into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market with a share of 86.67% in 2023 and is estimated to grow at the fastest CAGR of 6.5% during the forecast period.
  • In terms of region, the North America dominated the global market and accounted for 41.4% of the total market share in 2023. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Type Segment
      • 1.1.1.2 Type Segment
      • 1.1.1.3 Nyha Class Segment
      • 1.1.1.4 End-use Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 GVR's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
      • 1.9.1.1 Research Scope And Assumptions
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Primary Sources
  • 1.12 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot-1
  • 2.3 Segment Snapshot - 2
  • 2.4 Competitive Landscape

Chapter 3. Implantable Cardioverter Defibrillators Market Variables And Trends

  • 3.1 Implantable Cardioverter Defibrillators (ICD) Market Lineage Outlook
    • 3.1.1 Parent Market Outlook - Cardiac Rhythm Management Devices Market
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increasing Prevalence Of Cardiovascular Diseases & Other Heart Ailments
      • 3.2.1.2 Growing Technological & Product Development Activities
      • 3.2.1.3 Recognition Of Subcutaneous ICDs
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Product Recalls
      • 3.2.2.2 Gender & Regional Implantation Disparity And Cybersecurity Concerns
  • 3.3 Regulatory Framework
    • 3.3.1 Standards And Compliances
      • 3.3.1.1 North America
      • 3.3.1.2 Europe
      • 3.3.1.3 Asia Pacific (Apac)
      • 3.3.1.4 Latin America (Latam)
      • 3.3.1.5 Middle East & Africa (Mea)
    • 3.3.2 Reimbursement Scenario
      • 3.3.2.1 U.S.
      • 3.3.2.2 Canada
      • 3.3.2.3 Germany
      • 3.3.2.4 UK
      • 3.3.2.5 Japan
      • 3.3.2.6 Australia
      • 3.3.2.7 China
  • 3.4 Impact Of Covid-19 Pandemic
  • 3.5 Volume Of ICD Patients Suffering Heart Failure
  • 3.6 Percentage Of ICD Patients Undergoing Battery Change And Complication Rate
    • 3.6.1 Percentage Of ICD Patients Undergoing Battery Change
    • 3.6.2 Complication Rate
  • 3.7 Assessment Of Trials On ICD Therapies
    • 3.7.1 Multisite Stimulation In Cardiomyopathy (Mustic) Trial
    • 3.7.2 Multicenter Insync Randomized Clinical Evaluations (Miracle) Trial
    • 3.7.3 Comparison Of Medical Therapy, Pacing, And Defibrillation In Hf (Companion) Trial
    • 3.7.4 Cardiac Resynchronization-hf (Care-hf) Trial
    • 3.7.5 Multicenter Automative Defibrillator Implantation With Cardiac Resynchronization Therapy (Madit-crt) Trial
    • 3.7.6 The Danish Study To Accessess The Efficiency Of Implantable Cardioverter Defibrillators In Patients Suffering From Nonischemic Systolic Heart Failure Mortality (Danish) Trial
    • 3.7.7 British Trial
  • 3.8 Industry Analysis Tools
    • 3.8.1 Porter's Analysis
    • 3.8.2 Macroeconomic Analysis

Chapter 4. Implantable Cardioverter Defibrillators Market: Product Type Analysis

  • 4.1 Product Type Movement Analysis & Market Share, 2023 & 2030
  • 4.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Product Type (USD Million)
  • 4.3 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
    • 4.3.1 Transvenous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • 4.4 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
    • 4.4.1 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)

Chapter 5. Implantable Cardioverter Defibrillators Market: Type Analysis

  • 5.1 Type Movement Analysis & Market Share, 2023 & 2030
  • 5.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Type (USD Million)
  • 5.3 Single Chamber ICDs
    • 5.3.1 Common Conditions In Patients Using Single-chamber ICDs
    • 5.3.2 Single Chamber ICDs Market, 2018 - 2030 (USD Million)
  • 5.4 Dual Chamber ICDs
    • 5.4.1 Common Conditions In Patients Using Dual-chamber ICDs
    • 5.4.2 Dual Chamber ICDs Market, 2018 - 2030 (USD Million)
  • 5.5 Biventricular Devices
    • 5.5.1 Biventricular Devices Market, 2018 - 2030 (USD Million)

Chapter 6. Implantable Cardioverter Defibrillators Market: Nyha Class Analysis

  • 6.1 Nyha Class Movement Analysis & Market Share, 2023 & 2030
  • 6.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Nyha Class (USD Million)
  • 6.3 Nyha Class Ii
    • 6.3.1 Nyha Class Ii Market, 2018 - 2030 (USD Million)
  • 6.4 Nyha Class Iii
    • 6.4.1 Nyha Class Iii Market, 2018 - 2030 (USD Million)

Chapter 7. Implantable Cardioverter Defibrillators Market: End-use Analysis

  • 7.1 End-use Movement Analysis & Market Share, 2023 & 2030
  • 7.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By End-use (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Variation Of ICD Implants As Per The Type Of Hospital
    • 7.3.2 Hospitals Market, 2018 - 2030 (USD Million)
  • 7.4 Ambulatory Surgical Centers
    • 7.4.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8. Implantable Cardioverter Defibrillators Market: Regional Estimates & Trend Analysis

  • 8.1 Implantable Cardioverter Defibrillators Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Technology Used By Vendors For Patient Monitoring In Canada
      • 8.2.3.3 Canada Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Hypertension Cases In UK
      • 8.3.2.3 UK Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Causes Of Replacement According To Indication
      • 8.3.5.3 Italy Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 South Korea Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Thailand Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (Mea)
    • 8.6.1 Mea Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Analysis

  • 9.1 Company Categorization
  • 9.2 Participants' Overview
  • 9.3 Financial Performance
  • 9.4 Product Benchmarking
  • 9.5 Company Market Position Analysis
    • 9.5.1 Heat Map Analysis
  • 9.6 Swot-analysis
    • 9.6.1 Abbott
    • 9.6.2 Medtronic
    • 9.6.3 Biotronik Se & Co. Kg
    • 9.6.4 Boston Scientific Corporation
    • 9.6.5 Microport Scientific Corporation
    • 9.6.6 Livanova Plc
  • 9.7 Company Market Share Analysis, 2023
  • 9.8 Strategy Mapping
    • 9.8.1 Mergers & Acquisitions
    • 9.8.2 Product Launch
    • 9.8.3 Partnerships & Collaborations
    • 9.8.4 Product Approvals
    • 9.8.5 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Volume of ICD patients suffering heart failure
  • Table 4 Percentage Of ICD Patients Undergoing Battery Change
  • Table 5 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Product Type, 2018 - 2030 (USD Million)
  • Table 6 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By NYHA Class, 2018 - 2030 (USD Million)
  • Table 8 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By End-use, 2018 - 2030 (USD Million)
  • Table 9 Participant Organizations Involved in The Escape-Net Study-
  • Table 10 Key Companies Undertaking Mergers & Acquisitions.
  • Table 11 Key Companies Undertaking Product Launch
  • Table 12 Key Companies Undergoing Partnerships & Collaborations
  • Table 13 Key Companies Undergoing Product Approvals
  • Table 14 Key Companies Undergoing Others

List of Figures

  • Fig. 1 Implantable Cardioverter Defibrillators Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modelling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Market Snapshot
  • Fig. 10 Segment Snapshot - 1
  • Fig. 11 Segment Snapshot - 2
  • Fig. 12 Competitive Landscape
  • Fig. 13 Cardiac Rhythm Management Devices Market Value, 2023 (USD Billion)
  • Fig. 14 Implantable Cardioverter Defibrillators Market Dynamics
  • Fig. 15 Implantable Cardioverter Defibrillators Market: PORTER's Analysis
  • Fig. 16 Implantable Cardioverter Defibrillators Market: PESTEL Analysis
  • Fig. 17 Implantable Cardioverter Defibrillators Market: By Product Type: Key Takeaways
  • Fig. 18 Implantable Cardioverter Defibrillators Market, By Product Type: Market Share, 2023 & 2030
  • Fig. 19 Transvenous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 20 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 21 Implantable Cardioverter Defibrillators Market: By Type: Key Takeaways
  • Fig. 22 Implantable Cardioverter Defibrillators Market, By Type: Market Share, 2023 & 2030
  • Fig. 23 Common Conditions in Patients Using Single-Chamber ICDs
  • Fig. 24 Single Chamber ICDs Market, 2018 - 2030 (USD Million)
  • Fig. 25 Common Conditions in Patients Using Dual-Chamber ICDs
  • Fig. 26 Dual Chamber ICDs Market, 2018 - 2030 (USD Million)
  • Fig. 27 Biventricular Devices Market, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable Cardioverter Defibrillators Market: By NYHA Class: Key Takeaways
  • Fig. 29 Implantable Cardioverter Defibrillators Market, By NYHA Class: Market Share, 2023 & 2030
  • Fig. 30 NYHA Class II market, 2018 - 2030 (USD Million)
  • Fig. 31 NYHA Class III Market, 2018 - 2030 (USD Million)
  • Fig. 32 Implantable Cardioverter Defibrillators Market, By End-Use: Key Takeaways
  • Fig. 33 Implantable Cardioverter Defibrillators Market, By End-Use: Market Share, 2023 & 2030
  • Fig. 34 Variation of ICD implants as per the type of hospitals
  • Fig. 35 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 36 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Implantable Cardioverter Defibrillators Market Revenue, By Region, 2023 & 2030 (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 North America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 Technology Used by Vendors for Patient Monitoring in Canada
  • Fig. 45 Canada Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Hypertension Cases In UK (in Million)
  • Fig. 49 UK Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 Germany Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 France Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 Causes of Replacement According to Indication
  • Fig. 56 Italy Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Spain Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Denmark Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Sweden Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 63 Key Country Dynamics
  • Fig. 64 Norway Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Japan Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 China Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 India Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Australia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 South Korea Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Thailand Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Brazil Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Mexico Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Argentina Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 85 MEA Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 South Africa Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Saudi Arabia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Kuwait Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 94 Key Company Categorization
  • Fig. 95 Abbott-SWOT analysis
  • Fig. 96 Medtronic-SWOT analysis
  • Fig. 97 BIOTRONIK SE & Co. KG -SWOT analysis
  • Fig. 98 Boston Scientific Corporation-SWOT analysis
  • Fig. 99 MicroPort Scientific Corporation-SWOT analysis
  • Fig. 100 LivaNova PLC-SWOT analysis
  • Fig. 101 Company Market Share Analysis, 2023
  • Fig. 102 Strategy Mapping